Pernod Ricard Brown-Forman Merger Talks Confirmed

Pernod Ricard Brown-Forman merger talks confirmed after Brown-Forman's statement; traders will watch a mostly stock structure, approvals, and synergies.

March 26, 2026·2 min read
View all news articles
Flat vector of a whiskey bottle merging into a distillery silhouette illustrating the Pernod Ricard Brown-Forman merger.

KEY TAKEAWAYS

  • Brown-Forman confirmed discussions with Pernod Ricard about a potential combination akin to a merger of equals.
  • The combination is expected to produce significant synergies and create a global spirits leader.
  • Reports said talks would be structured mostly as stock and any deal could be weeks away.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Pernod Ricard Brown-Forman merger talks surfaced on March 26, 2026, after Brown-Forman said it was in discussions with Pernod Ricard. The company described the potential combination as akin to a "merger of equals" and said no terms had been agreed.

Brown-Forman Confirms Merger Discussions

Brown-Forman (NYSE: BF-A, BF-B) said in a statement at 6:30 p.m. ET on March 26, 2026, that it is engaged in discussions with Pernod Ricard (PDRDF, PRNDY) about a potential business combination. The company described the contemplated deal as akin to a merger of equals, drawing on the talent and expertise of both firms. The combination is expected to generate significant synergies and create a global spirits leader with enhanced scale, a powerful brand portfolio, and a balanced geographic footprint anchored by two iconic families.

The statement noted no agreement on terms has been reached, there is no assurance a transaction will occur, and any deal would require customary approvals. Brown-Forman said it regularly explores and evaluates strategic opportunities.

Deal Structure, Timing, and Market Reaction

Reports on March 26 indicated Pernod Ricard was considering an approach to acquire Brown-Forman. Initial coverage at 12:41 p.m. ET and 1:01 p.m. ET said Pernod Ricard was weighing a potential deal. Brown-Forman shares surged at 3:42 p.m. ET following the reports.

Later coverage at 7:04 p.m. ET said the talks would be structured mostly as a stock deal and that any transaction could be weeks away. Pernod Ricard had not commented publicly during this period.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Super Micro Lawsuit Follows DOJ Indictment

Super Micro Lawsuit Follows DOJ Indictment

Super Micro lawsuit follows a DOJ indictment alleging diversion of U.S.-assembled Nvidia GPU servers to China and raises investor uncertainty.

Henkel to Acquire Olaplex

Henkel to Acquire Olaplex

Henkel to Acquire Olaplex at $2.06 a share, creating a 55% premium that frames arbitrage and shareholder positioning ahead of an H2 2026 close.

Netflix Price Hike Raises Subscription Rates

Netflix Price Hike Raises Subscription Rates

Netflix price hike raises U.S. subscription rates to fund more content; traders must weigh higher revenue per user against churn and content-spend risks.

Corebridge Equitable Merger Creates Unified Retirement Firm

Corebridge Equitable Merger Creates Unified Retirement Firm

Corebridge Equitable merger creates a $22B retirement asset manager with $1.5T AUM, projecting cost synergies and EPS accretion that spur repositioning.

Apple U.S. Manufacturing Investment Adds Partners

Apple U.S. Manufacturing Investment Adds Partners

Apple U.S. manufacturing investment expands AMP partners, adding Bosch, Cirrus Logic, TDK and Qnity to boost U.S. component production. Investors will watch.

Wave Life Sciences WVE-007 Results Highlight Fat Loss

Wave Life Sciences WVE-007 Results Highlight Fat Loss

Wave Life Sciences WVE-007 results showed visceral fat reductions with modest weight change; a planned multidose trial will shape investor positioning.